Free access
Issue
Vet. Res.
Volume 35, Number 1, January-February 2004
Page(s) 1 - 38
DOI http://dx.doi.org/10.1051/vetres:2003037
How to cite this article Vet. Res. (2004) 1-38
References of Vet. Res. 35 1-38
  1. Adams L.G., Development of live Brucella vaccines, in: Adams L.G. (Ed.), Advances in brucellosis research, Texas A&M University Press, College Station, 1990, pp. 250-276.
  2. Adams L.G., Ficht T.A., Allen C.A., Derivation and evaluation of the rough rfbk brucellosis vaccine in cattle, in: Anonymous (Ed.), Memorias del III Foro Nacional de Brucelosis (20-21 July 1998), Acapulco, México, 1999, pp. 141-158.
  3. Allen C.A., Adams L.G., Ficht T.A., Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival, Infect. Immun. 66 (1998) 1008-1016 [PubMed].
  4. Alonso-Urmeneta B., Marín C.M., Aragón V., Blasco J.M., Díaz R., Moriyón I., Evaluation of lipopolysaccharides and polysaccharides of different epitopic structures in the indirect enzyme-linked immunosorbent assay for diagnosis of brucellosis in small ruminants and cattle, Clin. Diagn. Lab. Immunol. 5 (1998) 749-754 [PubMed].
  5. Alton G.G., Experiences with Brucella vaccines, in: Crawford R.M., Hidalgo R.J. (Eds.), Bovine brucellosis. An international Symposium, Texas A&M University Press, College Station, 1977, pp. 209-217.
  6. Alton G.G., Brucella suis, in: Nielsen K.H., Duncan J.R. (Eds.), Animal Brucellosis, CRC Press, Boca Raton, 1990, pp. 411-422.
  7. Alton G.G., Elberg S.S., Rev. 1 Brucella melitensis vaccine: A review of ten years of study, Vet. Bull. 371 (1967) 793-800.
  8. Alton G.G., Corner L.A., Plackett P., Vaccination against bovine brucellosis, Dev. Biol. Stand. 56 (1984) 643-647 [PubMed].
  9. Alton G.G., Jones L.M., Angus R.D., Verger J.M., Techniques for the brucellosis laboratory, INRA, Paris, France, 1988.
  10. Anonymous, Manual of Standards for Diagnostic Tests and Vaccines, Office International des Epizooties, Paris, France, 2001.
  11. Anonymous, Vaccin vivant cryodesseche de la brucellose (Brucella melitensis Rev 1) pour usage veterinaire, in: Conseil de l'Europe (Ed.), Pharmacopee Europeenne, 2001.
  12. Aragón V., Díaz R., Moreno E., Moriyón I., Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide, J. Bacteriol. 178 (1996) 1070-1079 [PubMed].
  13. Ariza J., Brucellosis: an update. The perspective from the Mediterranean basin, Rev. Med. Microbiol. 10 (1999) 125-135.
  14. Bagnat E., Maneti J.C., Prueba de eficacia de las vacunas antibrucélicas RB51 y cepa 19 en bovinos, Rev. Med. Vet. 81 (2002) 428-429.
  15. Bagnat E., Maneti J.C., Prueba de eficacia (potencia) de las vacunas antibrucélicas RB51 y cepa 19, en bovinos, Documento interno, SENASA, 2003.
  16. Blasco J.M., Brucella ovis, in: Nielsen K.H., Duncan J.R. (Eds.), Animal Brucellosis, CRC Press, Boca Raton, 1990, pp. 352-378.
  17. Blasco J.M., A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats, Prev. Vet. Med. 31 (1997) 275-283 [CrossRef] [PubMed].
  18. Bosseray N., Brucella melitensis Rev. 1 living attenuated vaccine: stability of markers, residual virulence and immunogenicity in mice, Biologicals 19 (1991) 355-363 [PubMed].
  19. Briones G.C., Iñón de Iannino N., Roset M., Vigliocco A.M., Paulo P.S., Ugalde R.A., Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells, Infect. Immun. 69 (2001) 4528-4535 [CrossRef] [PubMed].
  20. Cheville N.F., Jensen A.E., Halling S.M., Tatum F.M., Morfitt D.C., Hennager S.G., Frerichs W.M., Schurig G.G., Bacterial survival, lymph node changes, and immunologic responses of cattle vaccinated with standard and mutant strains of Brucella abortus, Am. J. Vet. Res. 53 (1992) 1881-1888 [PubMed].
  21. Cheville N.F., Stevens M.G., Jensen A.E., Tatum F.M., Halling S.M., Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus, Am. J. Vet. Res. 54 (1993) 1591-1597 [PubMed].
  22. Cheville N.F., Olsen S.C., Jensen A.E., Stevens M.G., Palmer M.V., Florance A.M., Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis, Am. J. Vet. Res. 57 (1996) 1153-1156 [PubMed].
  23. Ciuchini F., Adone R., Pasquali P., Coombs antiglobulin test using Brucella abortus 99 as antigen to detect incomplete antibodies induced by B. abortus RB51 vaccine in cattle, Clin. Diagn. Lab. Immunol. 9 (2002) 1398-1399 [CrossRef] [PubMed].
  24. Cloeckaert A., Weynants V.E., Godfroid J., Verger J.M., Grayon M., Zygmunt M.S., O-Polysaccharide epitopic heterogeneity at the surface of Brucella spp. studied by enzyme-linked immunosorbent assay and flow cytometry, Clin. Diagn. Lab. Immunol. 5 (1998) 862-870 [PubMed].
  25. Cloeckaert A., Zygmunt M.S., Guilloteau L.A., Brucella abortus vaccine strain RB51 produces low levels of M-like O-antigen, Vaccine 20 (2002) 1820-1822 [CrossRef] [PubMed].
  26. Cook W.E., Williams E.S., Thorne E.T., Kreeger T.J., Stout G., Bardsley K., Edwards H., Schurig G., Colby L.A., Enright F., Elzer P.H., Brucella abortus strain RB51 vaccination in elk. I. Efficacy of reduced dosage, J. Wildl. Dis. 38 (2002) 18-26 [PubMed].
  27. Corbeil L.B., Blau K., Inzana T.J., Nielsen K.H., Jacobson R.H., Corbeil R.R., Winter A.J., Killing of Brucella abortus by bovine serum, Infect. Immun. 56 (1988) 3251-3261 [PubMed].
  28. Crawford R.M., Hidalgo R.J., Immunization discussion, in: Crawford R.M., Hidalgo R.J. (Eds.), Bovine brucellosis. An international Symposium, Texas A&M University Press, College Station, 1977, pp. 218-265.
  29. Cunningham B., A difficult disease called brucellosis, in: Crawford R.M., Hidalgo R.J. (Eds.), Bovine brucellosis. An international Symposium, Texas A&M University Press, College Station, 1977, pp. 11-20.
  30. Davis D.S., Elzer P.H., Brucella vaccines in wildlife, Vet. Microbiol. 90 (2002) 533-544 [CrossRef] [PubMed].
  31. DelVecchio V.G., Kapatral V., Redkar R.J., Patra G., Mujer C., Los T., Ivanova N., Anderson I., Bhattacharyya A., Lykidis A., Reznik G., Jablonski L., Larsen N., D'Souza M., Bernal A., Mazur M., Goltsman E., Selkov E., Elzer P., Hagius S., O'Callaghan D., Letesson J.J., Haselkorn R., Kyrpides N., Overbeek R., The genome sequence of the facultative intracellular pathogen Brucella melitensis, Proc. Natl. Acad. Sci. USA 99 (2002) 443-448 [CrossRef] [PubMed].
  32. Detilleux P.G., Deyoe B.L., Cheville N.F., Entry and intracellular localization of Brucella spp. in Vero cells: fluorescence and electron microscopy, Vet. Pathol. 27 (1990) 317-328 [PubMed].
  33. Díaz R., Garatea P., Jones L.M., Moriyón I., Radial immunodiffusion test with a Brucella polysaccharide antigen for differentiating infected from vaccinated cattle, J. Clin. Microbiol. 10 (1979) 37-41 [PubMed].
  34. Díaz R., Toyos J., Salvo M.D., Pardo M.L., A simple method for the extraction of polysaccharide B from Brucella cells for use in the radial immunodiffusion test diagnosis of bovine brucellosis, Ann. Rech. Vet. 12 (1981) 35-39 [PubMed].
  35. Díaz-Aparicio E., Aragón V., Marín C.M., Alonso-Urmeneta B., Font M., Moreno E., Pérez-Gómez S., Blasco J.M., Díaz R., Moriyón I., Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O: 9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats, J. Clin. Microbiol. 31 (1993) 3136-3141 [PubMed].
  36. Díaz-Aparicio E., Marín C.M., Alonso-Urmeneta B., Aragón V., Pérez-Gómez S., Pardo M.L., Blasco J.M., Díaz R., Moriyón I., Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats, J. Clin. Microbiol. 32 (1994) 1159-1165 [PubMed].
  37. Douglas J.T., Palmer D.A., Use of monoclonal antibodies to identify the distribution of A and M epitopes on smooth Brucella species, J. Clin. Microbiol. 26 (1988) 1353-1356 [PubMed].
  38. Edmonds M.D., Cloeckaert A., Elzer P.H., Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis, Vet. Microbiol. 88 (2002) 205-221 [CrossRef] [PubMed].
  39. Edmonds M.D., Schurig G.G., Samartino L.E., Hoyt P.G., Walker J.V., Hagius S.D., Elzer P.H., Biosafety of Brucella abortus strain RB51 for vaccination of mature bulls and pregnant heifers, Am. J. Vet. Res. 60 (1999) 722-725 [PubMed].
  40. El-Idrissi A.H., Benkirane A., El-Maadoudi M., Bouslikhane M., Berrada J., Zerouali A., Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes, Rev. Sci Tech. Off. Int. Epizoot. 20 (2001) 741-747.
  41. Elzer P.H., Enright F.M., Colby L., Hagius S.D., Walker J.V., Fatemi M.B., Kopec J.D., Beal V.C., Schurig G.G., Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51, Am. J. Vet. Res. 59 (1998) 1575-1578 [PubMed].
  42. Elzer P.H., Enright F.M., McQuiston J.R., Boyle S.M., Schurig G.G., Evaluation of a rough mutant of Brucella melitensis in pregnant goats, Res. Vet. Sci. 64 (1998) 259-260 [PubMed].
  43. Fensterbank R., Plommet M., Vaccination against bovine brucellosis with a low dose of strain 19 administered by the conjunctival route. IV. Comparison between two methods of vaccination, Ann. Rech. Vet. 10 (1979) 131-139 [PubMed].
  44. Fernandez-Prada C.M., Nikolich M., Vemulapalli R., Sriranganathan N.M., Boyle S.M., Schurig G.G., Hadfield T.L., Hoover D.L., Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis, Infect. Immun. 69 (2001) 4407-4416 [CrossRef] [PubMed].
  45. Folch H., Rojas X., Oñate A.A., Alonso O., Leynan V., Jara U., Humoral and cellular responses in calves vaccinated with Brucella abortus RB51, Arch. Med. Vet. 95 (1995) 125-130.
  46. Foulongne V., Bourg G., Cazevieille C., Michaux-Charachon S., O'Callaghan D., Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis, Infect. Immun. 68 (2000) 1297-1303 [CrossRef] [PubMed].
  47. Freer E., Moreno E., Moriyón I., Pizarro-Cerdá J., Weintraub A., Gorvel J.P., Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts, J. Bacteriol. 178 (1996) 5867-5876 [PubMed].
  48. Freer E., Pizarro-Cerdá J., Weintraub A., Bengoechea J.A., Moriyón I., Hultenby K., Gorvel J.P., Moreno E., The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains, Infect. Immun. 67 (1999) 6181-6186 [PubMed].
  49. Godfroid J., Brucellosis in wildlife, Rev. Sci. Tech. Off. Int. Epizoot. 21 (2002) 277-286.
  50. Godfroid F., Taminiau B., Danese I., Denoel P.A., Tibor A., Weynants V.E., Cloeckaert A., Godfroid J., Letesson J.J., Identification of the perosamine synthetase gene of Brucella melitensis 16M and involvement of lipopolysaccharide O side chain in Brucella survival in mice and in macrophages, Infect. Immun. 66 (1998) 5485-5493 [PubMed].
  51. Godfroid F., Cloeckaert A., Taminiau B., Danese I., Tibor A., de Bolle X., Mertens P., Letesson J.J., Genetic organisation of the lipopolysaccharide O-antigen biosynthesis region of Brucella melitensis 16M (wbk), Res. Microbiol. 151 (2000) 655-668 [CrossRef] [PubMed].
  52. Grilló M.J., Bosseray N., Blasco J.M., In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines, Biologicals 28 (2000) 119-127 [CrossRef] [PubMed].
  53. Hamdy M.-E.R., El-Gibaly S.M., Montasser A.M., Comparison between immune responses and resistance induced in BALB/c mice vaccinated with RB51 and Rev. 1 vaccines and challenged with Brucella melitensis bv. 3, Vet. Microbiol. 88 (2002) 85-94 [CrossRef] [PubMed].
  54. Heinrichs D.E., Valvano M.A., Whitfield C., Biosynthesis and genetics of the lipopolysaccharide core, in: Brade H., Opal S.M., Vogel S.N., Morrison D.C. (Eds.), Endotoxin in health and disease, Marcel Dekker, New York, 1999, pp. 305-358.
  55. Hernández L., Ochoa D., Díaz E., Córdoba L., López M., Ontiveros C., Conferred protection for RB51 vaccine in goats, 54th Annual Brucellosis Research Conference. Nov 10-11. St Louis, 2001.
  56. Huber J.D., Beal V.C., Crawford R.P., Adams L.G., An evaluation of reduced dose Brucella abortus strain 19 vaccination, in: Adams L.G. (Ed.), Advances in brucellosis research, Texas A&M University Press, College Station, 1990, pp. 228-249.
  57. Iñón de Iannino N., Briones G.C., Tolmasky M., Ugalde R.A., Molecular cloning and characterization of cgs, the Brucella abortus cyclic beta(1-2) glucan synthetase gene: genetic complementation of Rhizobium meliloti ndvB and Agrobacterium tumefaciens chvB mutants, J. Bacteriol. 180 (1998) 4392-4400 [PubMed].
  58. Jacques I., Cloeckaert A., Limet J.N., Dubray G., Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella, J. Med. Microbiol. 37 (1992) 100-103 [PubMed].
  59. Jiménez de Bagüés M.P., Marín C.M., Blasco J.M., Effect of antibiotic therapy and strain-19 vaccination on the spread of Brucella melitensis within an infected dairy herd, Prev. Vet. Med. 11 (1991) 17-24.
  60. Jiménez de Bagüés M.P., Elzer P.H., Jones S.M., Blasco J.M., Enright F.M., Schurig G.G., Winter A.J., Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis, Infect. Immun. 62 (1994) 4990-4996 [PubMed].
  61. Jiménez de Bagüés M.P., Barberán M., Marín C.M., Blasco J.M., The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams, Vaccine 13 (1995) 301-304 [CrossRef] [PubMed].
  62. Jones L.M., Berman D.T., Antibody response, delayed type hypersensitivity and immunity in guinea pigs induced by smooth and rough strains of Brucella abortus, J. Infect. Dis. 124 (1975) 47-57.
  63. Jones L.M., Berman D.T., Moreno E., Deyoe B.L., Gilsdorf M.J., Huber J.D., Nicoletti P.L., Evaluation of a radial immunodiffusion test with polysaccharide B antigen for diagnosis of bovine brucellosis, J. Clin. Microbiol. 12 (1980) 753-760 [PubMed].
  64. Keenleyside W.J., Whitfield C., Genetics and biosynthesis of lipopolysaccharide O-antigens, in: Brade H., Opal S.M., Vogel S.N., Morrison D.C. (Eds.), Endotoxin in health and disease, Marcel Dekker, New York, 1999, pp. 331-358.
  65. Kreeger T.J., DeLiberto T.J., Olsen S.C., Edwards W.H., Cook W.E., Safety of Brucella abortus strain RB51 vaccine in non-target ungulates and coyotes, J. Wildl. Dis. 38 (2002) 552-557 [PubMed].
  66. Lopetegui P., Erradicación de brucelosis bovina en Chile. Experiencias en el uso de la vacuna cepa RB51, in: Luna-Martinez E., Suarez-Guemes F. (Eds.), III Foro Nacional de brucelosis, Acapulco, Mexico, 20-21 July, Anonymous,1998, pp. 159-179.
  67. Lord V.R., Rolo M.R., Cherwonogrodzky J.W., Evaluation of humoral immunity to Brucella sp in cattle by use of an agar-gel immunodiffusion test containing a polysaccharide antigen, Am. J. Vet. Res. 50 (1989) 1813-1816 [PubMed].
  68. Lord V.R., Schurig G.G., Cherwonogrodzky J.W., Marcano M.J., Melendez G.E., Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence, Am. J. Vet. Res. 59 (1998) 1016-1020 [PubMed].
  69. Lord V.R., Cherwonogrodzky J.W., Schurig G.G., Lord R.D., Marcano M.J., Melendez G.E., Venezuelan field trials of vaccines against brucellosis in swine, Am. J. Vet. Res. 59 (1998) 546-551 [PubMed].
  70. Luna-Martinez J.E., Mejia-Teran C., Brucellosis in Mexico: current status and trends, Vet. Microbiol. 90 (2002) 19-30 [CrossRef] [PubMed].
  71. MacMillan A.P., Conventional serological tests, in: Nielsen K.H., Duncan J.R. (Eds.), Animal Brucellosis, CRC Press, Boca Raton, 1990, pp. 153-197.
  72. Marín C.M., Moreno E., Moriyón I., Díaz R., Blasco J.M., Performance of competitive and indirect enzyme-linked immunosorbent assays, gel immunoprecipitation with native hapten polysaccharide, and standard serological tests in diagnosis of sheep brucellosis, Clin. Diagn. Lab. Immunol. 6 (1999) 269-272 [PubMed].
  73. Martin S.W., Meek A.H., Willeberg P., Veterinary Epidemiology. Principles and Methods, Iowa State University Press, Ames, Iowa, 1987.
  74. Martinez de Tejada G., Pizarro-Cerdá J., Moreno E., Moriyón I., The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides, Infect. Immun. 63 (1995) 3054-3061 [PubMed].
  75. McEwen A.D., Experiments on contagious abortion. Immunization studies with vaccines of graded virulence, Vet. Rec. 50 (1938) 1097-2002.
  76. McQuiston J.R., Vemulapalli R., Inzana T.J., Schurig G.G., Sriranganathan N.M., Fritzinger D., Hadfield T.L., Warren R.A., Snellings N., Hoover D.L., Halling S.M., Boyle S.M., Genetic characterization of a Tn5-disrupted glycosyltransferase gene homologue in Brucella abortus and its effect on lipopolysaccharide composition and virulence, Infect. Immun. 67 (1999) 3830-3835 [PubMed].
  77. Meyer M.E., Characterization of Brucella abortus strain 19 isolated from human and bovine tissues and fluids, Am. J. Vet. Res. 46 (1985) 902-904 [PubMed].
  78. Monreal D., Grillo M.J., Gonzalez D., Marin C.M., de Miguel M.J., Lopez-Goni I., Blasco J.M., Cloeckaert A., Moriyon I., Characterization of Brucella abortus O-Polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model, Infect. Immun. 71 (2003) 3261-3271 [CrossRef] [PubMed].
  79. Montaraz J.A., Winter A.J., Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice, Infect. Immun. 53 (1986) 245-251 [PubMed].
  80. Montaraz J.A., Winter A.J., Hunter D.M., Sowa B.A., Wu A.M., Adams L.G., Protection against Brucella abortus in mice with O-polysaccharide-specific monoclonal antibodies, Infect. Immun. 51 (1986) 961-963 [PubMed].
  81. Moreno E., Brucellosis in Central America, Vet. Microbiol. 90 (2002) 31-38 [CrossRef] [PubMed].
  82. Moriyón I., Gamazo C., Díaz R., Properties of the outer membrane of Brucella, Ann. Inst. Pasteur Microbiol. 138 (1987) 89-91 [PubMed].
  83. Mustafa A.A., Abusowa M., Field-oriented trial of the Chinese Brucella suis strain 2 vaccine on sheep and goats in Libya, Vet. Res. 24 (1993) 422-429 [PubMed].
  84. Nicoletti P.L., Vaccination, in: Nielsen K.H., Duncan J.R. (Eds.), Animal Brucellosis, CRC Press, Boca Raton, 1990, pp. 283-299.
  85. Nielsen K., Diagnosis of brucellosis by serology, Vet. Microbiol. 90 (2002) 447-459 [CrossRef] [PubMed].
  86. Olsen S., Palmer M.V., Stevens M.G., La nueva vacuna contra la brucelosis no causa falsos positivos, Hoard's Dairyman (Spanish edition), February issue, 1997, pp. 90-91.
  87. Olsen S.C., Immune responses and efficacy after administration of a commercial Brucella abortus RB51 vaccine to cattle, Vet. Ther. 3 (2000) 183-191.
  88. Olsen S.C., Responses of adult cattle to vaccination with a reduced dose of Brucella abortus strain RB51, Res. Vet. Sci. 69 (2000) 135-140 [CrossRef] [PubMed].
  89. Olsen S.C., Evans D., Hennager S.G., Cheville N.F., Stevens M.G., Serologic responses of Brucella abortus strain 19 calfhood-vaccinated cattle following adult vaccination with strain RB51, J. Vet. Diagn. Invest. 8 (1996) 451-454 [PubMed].
  90. Olsen S.C., Cheville N.F., Kunkle R.A., Palmer M.V., Jensen A.E., Bacterial survival, lymph node pathology, and serological responses of bison (Bison bison) vaccinated with Brucella abortus strain RB51 or strain 19, J. Wildl. Dis. 33 (1997) 146-151 [PubMed].
  91. Olsen S.C., Bricker B.J., Palmer M.V., Jensen A.E., Cheville N.F., Responses of cattle to two dosages of Brucella abortus strain RB51: serology, clearance and efficacy, Res. Vet. Sci. 66 (1999) 101-105 [CrossRef] [PubMed].
  92. Olsen S.C., Rhyan J.C., Gidlewski T., Palmer M.V., Jones A.H., Biosafety and antibody responses of adult bison bulls after vaccination with Brucella abortus strain RB51, Am. J. Vet. Res. 60 (1999) 905-908 [PubMed].
  93. Palmer M.V., Cheville N.F., Jensen A.E., Experimental infection of pregnant cattle with the vaccine candidate Brucella abortus strain RB51: pathologic, bacteriologic, and serologic findings, Vet. Pathol. 33 (1996) 682-691 [PubMed].
  94. Palmer M.V., Olsen S.C., Gilsdorf M.J., Philo L.M., Clarke P.R., Cheville N.F., Abortion and placentitis in pregnant bison (Bison bison) induced by the vaccine candidate, Brucella abortus strain RB51, Am. J. Vet. Res. 57 (1996) 1604-1607 [PubMed].
  95. Palmer M.V., Olsen S.C., Cheville N.F., Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle, Am. J. Vet. Res. 58 (1997) 472-477 [PubMed].
  96. Paulsen I.T., Seshadri R., Nelson K.E., Eisen J.A., Heidelberg J.F., Read T.D., Dodson R.J., Umayam L., Brinkac L.M., Beanan M.J., Daugherty S.C., Deboy R.T., Durkin A.S., Kolonay J.F., Madupu R., Nelson W.C., Ayodeji B., Kraul M., Shetty J., Malek J., Van-Aken S.E., Riedmuller S., Tettelin H., Gill S.R., White O., Salzberg S.L., Hoover D.L., Lindler L.E., Halling S.M., Boyle S.M., Fraser C.M., The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbionts, Proc. Natl. Acad. Sci. USA 99 (2002) 13148-13153 [CrossRef] [PubMed].
  97. Perry M.B., Bundle D.R., Lipopolysaccharide antigens and carbohydrates of Brucella, in: Adams L.G. (Ed.), Advances in brucellosis research, Texas A&M University Press, College Station, 1990, pp. 76-88.
  98. Pizarro-Cerdá J., Meresse S., Parton R.G., Van der Goot G., Sola-Landa A., López-Goñi I., Moreno E., Gorvel J.P., Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes, Infect. Immun. 66 (1998) 5711-5724 [PubMed].
  99. Pizarro-Cerdá J., Moreno E., Gorvel J.P., Brucella abortus invasion and survival within professional and nonprofessional phagocytes, Adv. Cell Mol. Biol. Membr. Org. 6 (1999) 201-232.
  100. Plommet M., Fensterbank R., La vaccination antibrucellique administree par voie conjonctivale, Dev. Biol. Stand. 56 (1984) 681-687 [PubMed].
  101. Plommet M., Plommet A.M., Immune serum-mediated effects on brucellosis evolution in mice, Infect. Immun. 41 (1983) 97-105 [PubMed].
  102. Plommet M., Renoux G., Philippon A., Gestin J., Fensterbank R., Transmission congenitale de la brucellose bovine d'une génération à l'autre, Bull. Acad. Vet. Fr. 44 (1971) 53-59 [PubMed].
  103. Qureshi N., Takayama K., Seydel U., Wang R., Cotter R.J., Agrawal P.K., Bush C.A., Kurtz R.S., Berman D.T., Structural analysis of the lipid A from the lipopolysaccharide of Brucella abortus, J. Endotoxin Res. 1 (1994) 137-148.
  104. Reeves P.R., Hobbs M., Valvano M.A., Skurnik M., Whitfield C., Coplin D., Kido N., Klena J., Maskell D., Raetz C.R., Rick P.D., Bacterial polysaccharide synthesis and gene nomenclature, Trends Microbiol. 4 (1996) 495-503 [CrossRef] [PubMed].
  105. Riley L.K., Robertson D.C., Brucellacidal activity of human and bovine polymorphonuclear leukocyte granule extracts against smooth and rough strains of Brucella abortus, Infect. Immun. 46 (1984) 231-236 [PubMed].
  106. Roerink J.H., Experience on the safety and effectiveness of 45-20 vaccine under field conditions, Vet. Rec. 85 (1969) 269-270 [PubMed].
  107. Rojas N., Freer E., Weintraub A., Ramirez M., Lind S., Moreno E., Immunochemical identification of Brucella abortus lipopolysaccharide epitopes, Clin. Diagn. Lab. Immunol. 1 (1994) 206-213 [PubMed].
  108. Roop R.M., Jeffers G., Bagchi T., Walker J., Enright F.M., Schurig G.G., Experimental infection of goat fetuses in utero with a stable, rough mutant of Brucella abortus, Res. Vet. Sci. 51 (1991) 123-127 [PubMed].
  109. Samartino L.E., Brucellosis in Argentina, Vet. Microbiol. 90 (2002) 71-80 [CrossRef] [PubMed].
  110. Samartino L.E., Enright F.M., Interaction of bovine chorioallantoic membrane explants with three strains of Brucella abortus, Am. J. Vet. Res. 53 (1992) 359-363 [PubMed].
  111. Samartino L.E., Fort M., Gregoret R., Schurig G.G., Use of Brucella abortus vaccine strain RB51 in pregnant cows after calfhood vaccination with strain 19 in Argentina, Prev. Vet. Med. 45 (2000) 193-199 [CrossRef] [PubMed].
  112. Schurig G.G., Roop R.M., Bagchi T., Boyle S., Buhrman D., Sriranganathan N.M., Biological properties of RB51; a stable rough strain of Brucella abortus, Vet. Microbiol. 28 (1991) 171-188 [CrossRef] [PubMed].
  113. Schurig G.G., Sriranganathan N., Corbel M.J., Brucellosis vaccines: past, present and future, Vet. Microbiol. 90 (2002) 479-496 [CrossRef] [PubMed].
  114. Soberon-Mobarak A., Díaz-Aparicio E., Torres-Armenta J., Adams L.G., Suarez-Guemes F., Absence of shedding of two B. abortus strains in goats after vaccination with live vaccines, Vaccine 18 (2000) 3018-3020 [CrossRef] [PubMed].
  115. Sola-Landa A., Pizarro-Cerdá J., Grilló M.J., Moreno E., Moriyón I., Blasco J.M., Gorvel J.P., López-Goñi I., A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence, Mol. Microbiol. 29 (1998) 125-138 [CrossRef] [PubMed].
  116. Spink W.W., The nature of brucellosis. Chapter 2, The Brucella cell, Lund Press Inc., Minneapolis, 1956.
  117. Stevens M.G., Olsen S.C., Antibody responses to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51, Infect. Immun. 64 (1996) 1030-1034 [PubMed].
  118. Stevens M.G., Hennager S.G., Olsen S.C., Cheville N.F., Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51, J. Clin. Microbiol. 32 (1994) 1065-1066 [PubMed].
  119. Stevens M.G., Olsen S.C., Cheville N.F., Comparative analysis of immune responses in cattle vaccinated with Brucella abortus strain 19 or strain RB51, Vet. Immunol. Immunopathol. 44 (1995) 223-235 [PubMed].
  120. Stevens M.G., Olsen S.C., Pugh G.W., Brees D., Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51, Infect. Immun. 63 (1995) 264-270 [PubMed].
  121. Suarez-Guemes F., Soberon-Mobarak A., Díaz-Aparicio E., Adams L.G., Evaluación de la vacuna RB51 y la vacuna experimental rfbK para su uso en caprinos, in: Anonymous (Ed.), Memorias del III Foro Nacional de Brucelosis (20-21 July 1998), Acapulco, México, 1999, pp. 191-204.
  122. Sulitzeanu D., Jones L.M., Stableforth A.W., Protective action of monospecific anti-Brucella sera in mice, Nature 175 (1955) 1040-1041 [PubMed].
  123. Sutherland S.S., Searson J., The immune response to Brucella abortus: the humoral response, in: Nielsen K.H., Duncan J.R. (Eds.), Animal Brucellosis, CRC Press, Boca Raton, 1990, pp. 65-81.
  124. Sutherland S.S., Robertson A.G., Le Cras D.V., Robertson G.M., Johnston J.M., Evans R.J., The effect of challenge with virulent Brucella abortus on beef cattle vaccinated as calves or adults with either Brucella abortus strain 19 or 45/20, Aust. Vet. J. 57 (1981) 470-473 [PubMed].
  125. Taylor A.W., McDiamird A., The stability of the avirulent characters of Brucella abortus strain 19 and strain 45/20 in lactating and pregnant cows, Vet. Rec. 61 (1949) 317-318.
  126. Ugalde J.E., Czibener C., Feldman M.F., Ugalde R.A., Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication, Infect. Immun. 68 (2000) 5716-5723 [CrossRef] [PubMed].
  127. Uzal F.A., Samartino L.E., Schurig G.G., Carrasco A., Nielsen K.H., Cabrera R.F., Taddeo H.R., Effect of vaccination with Brucella abortus strain RB51 on heifers and pregnant cattle, Vet. Res. Commun. 24 (2000) 143-151 [CrossRef] [PubMed].
  128. Van Metre D.C., Kennedy G.A., Olsen S.C., Hansen G.R., Ewalt D.R., Brucellosis induced by RB51 vaccine in a pregnant heifer, J. Am. Vet. Med. Assoc. 215 (1999) 1491-1493 [PubMed].
  129. Vargas O., Brucellosis in Venezuela, Vet. Microbiol. 90 (2002) 39-44 [CrossRef] [PubMed].
  130. Velasco J., Bengoechea J.A., Brandenburg K., Lindner B., Seydel U., González D., Zähringer U., Moreno E., Moriyón I., Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance, Infect. Immun. 68 (2000) 3210-3218 [CrossRef] [PubMed].
  131. Vemulapalli R., McQuiston J.R., Schurig G.G., Sriranganathan N.M., Halling S.M., Boyle S.M., Identification of and IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains, Clin. Diagn. Lab. Immunol. 6 (1999) 760-764 [PubMed].
  132. Vemulapalli R., He Y., Buccolo L.S., Boyle S.M., Sriranganathan N.M., Schurig G.G., Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation, Infect. Immun. 68 (2000) 3927-3932 [CrossRef] [PubMed].
  133. Vemulapalli R., He Y., Cravero S., Sriranganathan N.M., Boyle S.M., Schurig G.G., Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51, Infect. Immun. 68 (2000) 3286-3289 [CrossRef] [PubMed].
  134. Villarroel M., Grell M., Saenz R., Reporte de primer caso humano de aislamiento y tipificación de Brucella abortus RB51, Arch. Med. Vet. 32 (2000) 89-91.
  135. Winter A.J., Schurig G.G., Boyle S.M., Sriranganathan N.M., Bevins J.S., Enright F.M., Elzer P.H., Kopec J.D., Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4, Am. J. Vet. Res. 57 (1996) 677-683 [PubMed].
  136. Xin X., Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine, Vaccine 4 (1986) 212-216 [CrossRef] [PubMed].
  137. Zambrano A.J., Villava F.M., Schurig G.G., Cherwonogrodzky J.W., Preliminary results for the vaccination of pregnant cattle with Brucella abortus strain 19 or B. abortus RB51, Arch. Med. Vet. 28 (1995) 119-123.
  138. Zhan Y., Cheers C., Differential induction of macrophage-derived cytokines by live and dead intracellular bacteria in vitro, Infect. Immun. 63 (1995) 720-723 [PubMed].